Search results
Results From The WOW.Com Content Network
Shareholders will receive one common share of Grail for every six shares of Illumina, which will retain a 14.5% stake in the unit after the spinoff on June 24. Shares of Illumina were up 4% in ...
On Friday, Nasdaq Inc’s (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. Illumina, Inc. (NASDAQ:ILMN) was removed from ...
(Reuters) - Gene sequencing machine maker Illumina on Tuesday forecast 2024 sales from its core segment to decline, a sign that subdued demand for its instruments used in genetic tests could ...
Illumina expects full-year adjusted profit per share to be between $0.75 and $0.90, compared with its prior forecast of $1.25 to $1.50. The outlook reflects a tax expense impact of about $75 million.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and ...
Illumina has also reaffirmed its forecast for the first quarter and full-year 2024. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 ...
Illumina Inc., 437 F. Supp. 2d 252 (D. Del. 2006), was a United States patent law case heard before the United States District Court for the District of Delaware. In its ruling, the district court was the first court to hold that reputational harm could be sufficient to establish standing in an action for correction of named inventor under 35 U ...
Hi, I work for Illumina (COI declared above), and would like to request some corrections and updates to this Wikipedia article to improve its accuracy. 1. Lead : Please change "140 countries" to "155 countries" and change citation to this: [ 1 ]